Topotecan (T) and cyclophosphamide (CY) in second line treatment of advanced ovarian cancer (AOC): a gineco phase II trial
| Autor: | Mayer, F., Peaud, P.Y., Tigaud, J.D., Kaminsky, M.C., Culine, S., Walter, S., Barletta, H., Bastit, P., Vannetzel, J.M., Pujade-Lauraine, E. |
|---|---|
| Zdroj: | In European Journal of Cancer 2001 37 Supplement 6:S324-S324 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect